Insider Transactions in Q3 2025 at Lyell Immunopharma, Inc. (LYEL)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2025
|
Lynn Seely President and CEO |
SELL
Open market or private sale
|
Direct |
406
-1.15%
|
$4,060
$10.34 P/Share
|
|
Aug 12
2025
|
Charles W. Newton Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
136
-1.53%
|
$1,360
$10.34 P/Share
|
|
Aug 12
2025
|
Gary K. Lee Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
136
-1.5%
|
$1,360
$10.34 P/Share
|
|
Aug 12
2025
|
Stephen J. Hill Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
94
-1.05%
|
$940
$10.34 P/Share
|
|
Aug 11
2025
|
Lynn Seely President and CEO |
SELL
Open market or private sale
|
Direct |
391
-1.1%
|
$3,910
$10.53 P/Share
|
|
Aug 11
2025
|
Charles W. Newton Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
131
-1.45%
|
$1,310
$10.53 P/Share
|
|
Aug 11
2025
|
Gary K. Lee Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
131
-1.42%
|
$1,310
$10.53 P/Share
|
|
Aug 11
2025
|
Stephen J. Hill Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
91
-1.01%
|
$910
$10.53 P/Share
|